The court’s determination that these particular polymorph claims would have been obvious shows that with prior art examples disclosing processes that produce the subsequently claimed crystal form and ...
Robert Millonig, Ph.D., Deepa Shiwcharan Pharm.D. Companies interested in researching, developing, and commercializing pharmaceutical compounds should be aware of not only strategies for patenting the ...
As Reunion Neuroscience REUN and Mindset Pharma MSSTF continue their court battle over claims on a novel 4-OH-DiPT prodrug, private biotech company Terran Biosciences has also filed a patent ...
Please provide your email address to receive an email when new articles are posted on . Terran Biosciences was issued patents for four patents in psychedelic treatments. Patents were issued for the ...
NEW YORK, March 20, 2024 /PRNewswire/ -- Immunic, Inc. (IMUX) (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic ...
Jicheng Yang of Wanhuida Intellectual Property considers whether a notable Beijing Intellectual Property Court decision signals a change to assessing inventive step in polymorph patents in China On ...
Min Son of Hanol IP & Law reports on a ruling by the Supreme Court of Korea that will make it easier to obtain polymorph patents of known chemicals in the country Patenting polymorphs of crystalline ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results